Aptevo Therapeutics Inc (APVO) — Cash Flow Reinvestment Rate
Latest as of March 2023:
0.00x
Aptevo Therapeutics Inc (APVO) has a Cash Flow Reinvestment Rate of 0.00x as of March 2023, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $4.57 Million. Check APVO cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$0.00
Capex + Investments
Operating Cash Flow
$4.57 Million
USD
Capital Expenditures
$0.00
USD
Annual Cash Flow Reinvestment Rate for Aptevo Therapeutics Inc (None–None)
Year-by-year capital reinvestment analysis for Aptevo Therapeutics Inc. For live market cap and broader valuation context, see market value of Aptevo Therapeutics Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow